Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

196 ARTÍCULOS , VIENDO DEL 61 AL 75

Imaging biomarkers in neurodegeneration: current and future practices

Young PNE, Estarellas M, Coomans E, Srikrishna M, Beaumont H, Maass A, Venkataraman AV, Lissaman R, Jiménez D, Betts MJ, McGlinchey E, Berron D, O'Connor A, Fox NC, Pereira JB, Jagust W, Carter SF, Paterson RW, Schöll M.

Alzheimers Res Ther. 2020 Apr 27;12(1):49. doi: 10.1186/s13195-020-00612-7.

Insulin and leptin as potential cognitive enhancers in metabolic disorders and Alzheimer's disease

Mejido DCP, Peny JA, Vieira MNN, Ferreira ST, De Felice FG.

Neuropharmacology. 2020 Jul;171:108115. doi: 10.1016/j.neuropharm.2020.108115. Epub 2020 Apr 25.

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer's disease and mild cognitive impairment

Liu W, Lin H, He X, Chen L, Dai Y, Jia W, Xue X, Tao J, Chen L.

Transl Psychiatry. 2020 Apr 29;10(1):125. doi: 10.1038/s41398-020-0801-2.

Current and Future of Alzheimer's Therapy with the Best Approach

Singh H, Chawla V, Bala R, Dureja H.

CNS Neurol Disord Drug Targets. 2020;19(9):691-697. doi: 10.2174/1871527319666200430000538.

Tryptophan metabolites modify brain Aβ peptide degradation: A role in Alzheimer's disease?

Maitre M, Klein C, Patte-Mensah C, Mensah-Nyagan AG.

Prog Neurobiol. 2020 Jul;190:101800. doi: 10.1016/j.pneurobio.2020.101800. Epub 2020 Apr 29.

Utility of Animal Models to Understand Human Alzheimer's Disease, Using the Mastermind Research Approach to Avoid Unnecessary Further Sacrifices of Animals

Qin T, Prins S, Groeneveld GJ, Van Westen G, de Vries HE, Wong YC, Bischoff LJM, de Lange ECM.

Int J Mol Sci. 2020 Apr 30;21(9):3158. doi: 10.3390/ijms21093158.

Commentary on "The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum"

Beaudreau SA, Schneider L.

Am J Geriatr Psychiatry. 2020 Jul;28(7):745-747. doi: 10.1016/j.jagp.2020.04.007. Epub 2020 Apr 15.

Combination Drug Therapy for the Management of Alzheimer's Disease

Kabir MT, Uddin MS, Mamun AA, Jeandet P, Aleya L, Mansouri RA, Ashraf GM, Mathew B, Bin-Jumah MN, Abdel-Daim MM.

Int J Mol Sci. 2020 May 5;21(9):3272. doi: 10.3390/ijms21093272.

Clinical significance of fluid biomarkers in Alzheimer's Disease

Lewczuk P, Łukaszewicz-Zając M, Mroczko P, Kornhuber J.

Pharmacol Rep. 2020 Jun;72(3):528-542. doi: 10.1007/s43440-020-00107-0. Epub 2020 May 8.

Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer's Disease Spectrum with Amyloid PET Imaging

Lim HJ, Park JE, Kim BC, Choi SM, Song MK, Cho SH, Seo HJ, Kim J, Song HC, Choi KY, Lee JJ, Kim HW, Ha JM, Song WK, Park SG, Lee JS, Lee KH.

J Alzheimers Dis. 2020;75(3):949-958. doi: 10.3233/JAD-191331.

Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer's Disease

Pyun JM, Kang MJ, Ryoo N, Suh J, Youn YC, Park YH, Kim S.

J Alzheimers Dis. 2020;75(3):685-696. doi: 10.3233/JAD-200104.

Relevance of biomarkers across different neurodegenerative diseases

Ehrenberg AJ, Khatun A, Coomans E, Betts MJ, Capraro F, Thijssen EH, Senkevich K, Bharucha T, Jafarpour M, Young PNE, Jagust W, Carter SF, Lashley T, Grinberg LT, Pereira JB, Mattsson-Carlgren N, Ashton NJ, Hanrieder J, Zetterberg H, Schöll M, Paterson RW.

Alzheimers Res Ther. 2020 May 13;12(1):56. doi: 10.1186/s13195-020-00601-w.

The age-related microglial transformation in Alzheimer's disease pathogenesis

Yuan C, Aierken A, Xie Z, Li N, Zhao J, Qing H.

Neurobiol Aging. 2020 Aug;92:82-91. doi: 10.1016/j.neurobiolaging.2020.03.024. Epub 2020 Apr 15.

Oxidative Stress and Dementia in Alzheimer's Patients: Effects of Synbiotic Supplementation

Ton AMM, Campagnaro BP, Alves GA, Aires R, Côco LZ, Arpini CM, Guerra E Oliveira T, Campos-Toimil M, Meyrelles SS, Pereira TMC, Vasquez EC.

Oxid Med Cell Longev. 2020 Jan 13;2020:2638703. doi: 10.1155/2020/2638703. eCollection 2020.

What to make of equivocal amyloid imaging results

Burrell JR, Foxe D, Leyton C, Piguet O, Hodges JR.

Neurocase. 2020 Jun;26(3):137-146. doi: 10.1080/13554794.2020.1764056. Epub 2020 May 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias